Mark Robert Baker Insider Trading
Get free email notifications about insider trading for Mark Robert Baker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Robert Baker. Mark Robert Baker is a CEO in PROGENICS PHARMACEUTICALS INC ($PGNX) and an Chief Executive Officer in PROGENICS PHARMACEUTICALS INC ($PGNX) and a General Counsel in PROGENICS PHARMACEUTICALS INC ($PGNX) and a President in PROGENICS PHARMACEUTICALS INC ($PGNX).
Address: 777 OLD SAW MILL RIVER ROAD TARRYTOWN 10591 NY
Companies in which Mark Robert Baker is an Insider
PROGENICS PHARMACEUTICALS INC
Trading Symbol: PGNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Robert Baker: Chief Executive Officer, CEO, President, General Counsel
Holdings: 161,141 shares
Current Value: $1,535,674
Latest Transaction: Mar 05 2019
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Robert Baker
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2019 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | Chief Executive Off ... | Option Exercise | A | 4.52 | 192,500 | 870,100 | 192,500 | |
Mar 02 2018 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | Chief Executive Off ... | Option Exercise | A | 6.62 | 201,250 | 1,332,275 | 201,250 | |
Mar 07 2017 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | Chief Executive Off ... | Option Exercise | A | 11.32 | 175,000 | 1,981,000 | 175,000 | |
Mar 03 2016 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | CEO | Option Exercise | A | 4.52 | 175,000 | 791,000 | 175,000 | |
Mar 04 2015 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | CEO | Option Exercise | A | 6.65 | 132,000 | 877,800 | 132,000 | |
Mar 04 2014 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | CEO | Option Exercise | A | 4.70 | 132,000 | 620,400 | 132,000 | |
Apr 08 2013 | PGNX | PROGENICS PHARMACE ... | Baker Mark Robert | CEO | Option Exercise | A | 5.03 | 120,000 | 603,600 | 120,000 |